MSB 2.45% 99.5¢ mesoblast limited

Cell Therapy News/Articles, page-2225

  1. 442 Posts.
    lightbulb Created with Sketch. 45
    It looks like a private company with strong links to India and offices in the US and Mexico. A team of 7 management and 10 advisory doctors. That doesn't diminish it as a competitor but raises questions about funding requirements. I see there is no government backing for the trials they are doing on CV-19.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.